Hypermethylation of RASSF1A in human and rhesus placentas

125Citations
Citations of this article
65Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The pseudomalignant nature of the placenta prompted us to search for tumor suppressor gene hypermethylation, a phenomenon widely reported in cancer, in the human placenta. Nine tumor suppressor genes were studied. Hypermethylation of the Ras association domain family 1 A (RASSF1A) gene was found in human placentas from all three trimesters of pregnancy but was absent in other fetal tissues. Hypermethylation of Rassf1 was similarly observed in placentas from the rhesus monkey but not the mouse. An inverse relationship between RASSF1A promoter methylation and gene expression was demonstrated by bisulfite sequencing of microdissected placental cells and immunohistochemical staining of placental tissue sections using an anti-RASSF1A antibody. Treatment of choriocarcinoma cell lines, JAR and JEG3, by 5-aza-2′-deoxycytidine and trichostatin A led to reduction in RASSF1A methylation but increased expression. These observations extend the analogy between the primate placenta and malignant tumors to the epigenetic level. Copyright © American Society for Investigative Pathology.

Cite

CITATION STYLE

APA

Chiu, R. W. K., Chim, S. S. C., Wong, I. H. N., Wong, C. S. C., Lee, W. S., To, K. F., … Lo, Y. M. D. (2007). Hypermethylation of RASSF1A in human and rhesus placentas. American Journal of Pathology, 170(3), 941–950. https://doi.org/10.2353/ajpath.2007.060641

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free